Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-27 | Q1 FY262026-03-28 | Q4 FY252025-12-31 | Q3 FY252025-09-27 | Q2 FY252025-06-28 | Q1 FY252025-03-29 | Q4 FY242024-12-31 | Q3 FY242024-09-28 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.99B | $11.01B | $12.22B | $11.12B | $10.86B | $10.36B | $11.40B | $10.60B |
| Cost of revenue | $7.11B | $6.58B | $7.20B | $6.54B | $6.45B | $6.13B | $6.57B | $6.27B |
| Gross profit | $4.88B | $4.43B | $5.01B | $4.58B | $4.41B | $4.24B | $4.82B | $4.33B |
| Gross margin | 40.7% | 40.3% | 41.0% | 41.2% | 40.6% | 40.9% | 42.3% | 40.8% |
| Research and development | $364.00M | $336.00M | $356.00M | $346.00M | $352.00M | $342.00M | $374.00M | $346.00M |
| Selling, general and administrative | $2.33B | $2.18B | $2.35B | $2.16B | $2.14B | $2.08B | $2.20B | $2.10B |
| Operating expenses | $2.80B | $2.57B | $2.76B | $2.64B | $2.58B | $2.52B | $2.81B | $2.49B |
| Operating income | $2.09B | $1.86B | $2.26B | $1.94B | $1.83B | $1.72B | $2.02B | $1.84B |
| Operating margin | 17.4% | 16.9% | 18.5% | 17.4% | 16.9% | 16.6% | 17.7% | 17.4% |
| EBITDA | $2.09B | $2.65B | $3.03B | $3.60B | $1.74B | $2.52B | $2.99B | $3.69B |
| Interest income | $207.00M | $233.00M | $258.00M | $234.00M | $297.00M | $203.00M | $227.00M | $277.00M |
| Interest expense | −$401.00M | −$354.00M | −$365.00M | −$347.00M | −$404.00M | −$303.00M | −$317.00M | −$356.00M |
| Income before taxes | $1.91B | $1.73B | $2.15B | $1.83B | $1.71B | $1.62B | $1.94B | $1.74B |
| Income taxes | $167.00M | $70.00M | $153.00M | $207.00M | $92.00M | $95.00M | $150.00M | $99.00M |
| Net income | $1.74B | $1.66B | $1.97B | $1.62B | $1.62B | $1.51B | $1.82B | $1.63B |
| Net margin | 14.5% | 15.0% | 16.1% | 14.6% | 14.9% | 14.6% | 16.0% | 15.4% |
| EPS, basic | $4.68 | $4.44 | $5.25 | $4.28 | $4.28 | $3.99 | $4.79 | $4.26 |
| EPS, diluted | $4.68 | $4.43 | $5.21 | $4.27 | $4.28 | $3.98 | $4.80 | $4.25 |
| Diluted shares | 371.00M | 373.00M | 377.00M | 378.00M | 378.00M | 379.00M | 381.00M | 384.00M |
Figures describe Thermo Fisher shares, not any token. As of Jul 31, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.